Less than two weeks after Option Care Health announced a proposed $3.6 billion acquisition of home health provider Amedisys, Addus HomeCare Chair and CEO Dirk Allison said his company is on the hunt for home health firms.
“We are looking at strategic acquisitions in states like Tennessee,…
Source: www.modernhealthcare.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
